Aster DM Healthcare's Q2 FY 2025-26 Quarterly Results
- 07 Nov 2025
Result Summary
- Aster DM Healthcare Ltd reported a 10.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 9.3%.
- Its expenses for the quarter were up by 8.3% QoQ and 8.7% YoY.
- The net profit increased 29.7% QoQ and increased 14.7% YoY.
- The earnings per share (EPS) of Aster DM Healthcare Ltd stood at 2.13 during Q2 FY 2025-26.
Financial Statments for Q2 FY 2025-26
Total Income | 1225.46 | 1111.05 | 1121.68 | 10.3% | 9.3% |
Total Expenses | 1044.25 | 964.50 | 960.43 | 8.3% | 8.7% |
Profit Before Tax | 180.85 | 142.16 | 161.25 | 27.2% | 12.2% |
Tax | 45.54 | 42.88 | 52.89 | 6.2% | -13.9% |
Profit After Tax | 121.31 | 93.56 | 105.76 | 29.7% | 14.7% |
Earnings Per Share | 2.13 | 1.67 | 1.94 | 27.5% | 9.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Aster DM Healthcare Ltd is a prominent player in the healthcare services industry, primarily operating in India and the Middle East. The company provides a wide range of healthcare services, including hospitals, clinics, and pharmacies. Aster DM Healthcare is known for its multi-specialty hospitals that offer comprehensive medical care across various disciplines. In recent times, the company has focused on expanding its presence in the Middle East and enhancing its service offerings through technological advancements and strategic partnerships. However, specific recent major developments about the company are not available in the provided data.
Revenue
In the second quarter of the fiscal year 2026 (Q2FY26), Aster DM Healthcare Ltd reported a total income of ₹1225.46 crores, showcasing a growth of 10.3% from the previous quarter (Q1FY26) where the total income was ₹1111.05 crores. Compared to the same quarter in the previous fiscal year (Q2FY25), the total income grew by 9.3%, indicating an upward trend in revenue generation. This performance reflects the company's revenue growth trajectory over both the quarterly and yearly periods.
Profitability
Profitability metrics for Aster DM Healthcare Ltd in Q2FY26 reflect a positive trend with a Profit Before Tax (PBT) of ₹180.85 crores, which increased by 27.2% compared to the preceding quarter (Q1FY26), where PBT was ₹142.16 crores. Year-over-year, PBT rose by 12.2%, from ₹161.25 crores in Q2FY25. The Profit After Tax (PAT) for Q2FY26 was ₹121.31 crores, marking a 29.7% increase from Q1FY26's PAT of ₹93.56 crores and a 14.7% increase from the PAT of ₹105.76 crores in Q2FY25. The Earnings Per Share (EPS) for Q2FY26 was ₹2.13, reflecting a quarter-over-quarter increase of 27.5% and a year-over-year increase of 9.8%.
Operating Metrics
Total expenses for Aster DM Healthcare Ltd in Q2FY26 amounted to ₹1044.25 crores, which is an 8.3% increase from Q1FY26 when expenses were ₹964.50 crores. Compared to Q2FY25, expenses grew by 8.7% from ₹960.43 crores. The tax expense for Q2FY26 was ₹45.54 crores, a 6.2% increase from the previous quarter's tax of ₹42.88 crores, but a decline of 13.9% from Q2FY25's tax expense of ₹52.89 crores. These figures reflect the company's operational cost dynamics and tax obligations over the reported periods.